Cite Filings / DSGN / 0001104659-23-118212
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Design Therapeutics, Inc. · Filed 2023-11-14 · Acc 0001104659-23-118212

Documents 1

  • SC 13G/A Amended Statement of Ownership , tm2330558d1_sc13ga.htm

Around this filing

  • 2024-01-23 SC 13G/A Amended Statement of Ownership
  • 2023-11-14 SC 13G/A Amended Statement of Ownership
  • 2023-11-13 10-Q Quarterly Report
  • 2023-11-13 8-K Results of operations
  • 2023-09-07 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · DRIEHAUS CAPITAL MANAGEMENT LLC 5.83%
  2. 2025-11-18 SCHEDULE 13D/A · Logos Global Management LP 4.4%
  3. 2025-11-12 SCHEDULE 13D/A · Logos Global Management LP 5.7%
  4. 2024-08-13 SC 13D/A · Arsani William 7.5%
  5. 2022-03-31 SC 13D · Logos Global Management LP 5.0%
Loading tm2330558d1_sc13ga.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…